Fas ligand in human serum

Nature Medicine
M TanakaS Nagata

Abstract

The Fas ligand (FasL), a member of the tumor necrosis factor family, induces apoptosis in Fas-bearing cells. The membrane-bound human FasL was found to be converted to a soluble form (sFasL) by the action of a matrix metalloproteinase-like enzyme. Two neutralizing monoclonal anti-human FasL antibodies were identified, and an enzyme-linked immunosorbent assay (ELISA) for sFasL in human sera was established. Sera from healthy persons did not contain a detectable level of sFasL, whereas those from patients with large granular lymphocytic (LGL) leukemia and natural killer (NK) cell lymphoma did. These malignant cells constitutively expressed FasL, whereas peripheral NK cells from healthy persons expressed FasL only on activation. These results suggested that the systemic tissue damage seen in most patients with LGL leukemia and NK-type lymphoma is due to sFasL produced by these malignant cells. Neutralizing anti-FasL antibodies or matrix metalloproteinase inhibitors may be of use in modulating such tissue damage.

References

Oct 1, 1992·Cardiovascular Drugs and Therapy·A J CowleyJ R Hampton
Jan 1, 1992·Annual Review of Immunology·P Vassalli
Jun 1, 1992·Leukemia Research·S SadullahD G Oscier
Sep 11, 1990·Nucleic Acids Research·S Mizushima, S Nagata
Nov 16, 1995·Nature·J E Gumperz, P Parham
Nov 17, 1995·Science·T S GriffithT A Ferguson
Oct 1, 1993·Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy·L B Owen-SchaubR J Ford
Mar 1, 1994·The Journal of Experimental Medicine·T Suda, S Nagata
Jun 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·N HiramatsuT Kamada
Feb 1, 1995·The Journal of Experimental Medicine·F VignauxP Golstein
Mar 1, 1995·The Journal of Experimental Medicine·H AraseT Saito
Mar 10, 1995·Science·S Nagata, P Golstein
Jan 1, 1995·Immunology Today·S Nagata, T Suda
Oct 19, 1995·Nature·D BellgrauR C Duke
Aug 26, 1993·Nature·J OgasawaraS Nagata
Apr 11, 1995·Proceedings of the National Academy of Sciences of the United States of America·W M Yokoyama
Oct 1, 1994·International Immunology·T TakahashiS Nagata
Mar 5, 1996·Proceedings of the National Academy of Sciences of the United States of America·M AdachiS Nagata

❮ Previous
Next ❯

Citations

Nov 5, 1999·The Journal of Pathology·M MüschenD Häussinger
May 18, 1999·International Journal of Cancer. Journal International Du Cancer·L Peduto EberlL Juillerat-Jeanneret
Feb 7, 2001·International Journal of Cancer. Journal International Du Cancer·M MottoleseF M Venanzi
Mar 4, 1998·European Journal of Immunology·I JeremiasK M Debatin
Oct 12, 2000·Journal of Cellular Physiology·M UwaiK Hatake
Jan 17, 2002·The Journal of Pathology·Tineke TimmerSteven de Jong
Apr 16, 1998·Springer Seminars in Immunopathology·J AllisonH Yagita
Aug 24, 2001·Brain Tumor Pathology·M IchinoseK Tabuchi
May 25, 2001·International Journal of Hematology·K KatoM Kikuchi
Jan 8, 1999·International Journal of Clinical & Laboratory Research·F SilvestrisF Dammacco
Jun 5, 2004·Developmental and Comparative Immunology·Harjeet KaurDonald L Evans
May 4, 2004·Human Immunology·Hui Lin ChuaZacharie Brahmi
Dec 5, 2002·Archives of Biochemistry and Biophysics·Tracy Vargo-GogolaLynn M Matrisian
Jul 24, 2002·Clinica Chimica Acta; International Journal of Clinical Chemistry·Kazunori HoshimotoTakeyoshi Ohkura
Oct 10, 2002·Fertility and Sterility·Juan A Garcia-VelascoAydin Arici
Jan 5, 2000·Journal of Immunological Methods·T W KuijpersD Roos
Mar 22, 2000·Journal of Immunological Methods·N HollerP Schneider
Sep 5, 2002·Mathematical Biosciences·Steven D WebbReginald G Fish
May 17, 2000·Pharmaceutica acta Helvetiae·P Schneider, J Tschopp
Feb 1, 1997·Journal of Neuroimmunology·S ChandlerA J Gearing
May 1, 1997·Immunology Today·T S Griffith, T A Ferguson
Mar 19, 1999·Immunology Today·J O'ConnellF Shanahan
Jun 4, 1999·Immunology Today·S YamamotoK Matsuura
Apr 15, 1997·Human Immunology·G Berke
Feb 18, 1999·Toxicology Letters·P H Krammer
Feb 19, 2002·Journal of the American College of Cardiology·Masumi ShimizuToshio Ogihara
Dec 18, 1998·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·G FeldmannA Bringuier
Feb 28, 2002·Free Radical Biology & Medicine·Mauro ProvincialiGiovanni Bernardini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis